FIM
CRSP icon

Freedom Investment Management’s CRISPR Therapeutics CRSP Stock Holding History

Freedom Investment Management’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-9,000
Closed -$438K – 275
2025
Q2 		$438K Sell
9,000
-506
-5% -$19.6K 0.03% 484
2025
Q1 		$323K Sell
9,506
-511
-5% -$21.7K 0.03% 566
2024
Q4 		$394K Buy
10,017
+1,856
+23% +$87.6K 0.03% 497
2024
Q3 		$383K Sell
8,161
-428
-5% -$21.7K 0.03% 515
2024
Q2 		$464K Buy
8,589
+2,030
+31% +$117K 0.04% 447
2024
Q1 		$447K Sell
6,559
-1,888
-22% -$135K 0.04% 474
2023
Q4 		$529K Buy
8,447
+78
+0.9% +$4.31K 0.04% 419
2023
Q3 		$380K Sell
8,369
-699
-8% -$36.1K 0.05% 433
2023
Q2 		$509K Buy
9,068
+420
+5% +$23.8K 0.06% 390
2023
Q1 		$391K Sell
8,648
-67
-0.8% -$3.25K 0.04% 476
2022
Q4 		$354K Sell
8,715
-17,722
-67% -$940K 0.04% 531
2022
Q3 		$1.73M Buy
26,437
+13,638
+107% +$988K 0.2% 125
2022
Q2 		$778K Sell
12,799
-5,258
-29% -$309K 0.08% 311
2022
Q1 		$1.13M Sell
18,057
-6,172
-25% -$388K 0.1% 259
2021
Q4 		$1.84M Buy
24,229
+287
+1% +$25.1K 0.13% 194
2021
Q3 		$2.68M Buy
23,942
+2,596
+12% +$326K 0.2% 116
2021
Q2 		$3.46M Sell
21,346
-1,663
-7% -$202K 0.26% 87
2021
Q1 		$2.8M Buy
+23,009
New +$3.47M 0.22% 104

Other funds holding CRSP

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Freedom Investment Management's CRSP Position: Q3 2025 in Review

Freedom Investment Management sold out of CRISPR Therapeutics (CRSP) in Q3 2025, closing a stake of 9,000 shares — an estimated $438K sold.

Freedom Investment Management first reported a position in CRSP in Q1 2021 and held it in 18 quarters. The position peaked at $3.46M in Q2 2021. 440 funds tracked by Wall St. Rank hold CRSP as of Q3 2025.

  • Freedom Investment Management reported no remaining CRISPR Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Freedom Investment Management sold 9,000 CRISPR Therapeutics shares in Q3 2025, an estimated $438K.
  • Freedom Investment Management first reported a position in CRISPR Therapeutics in Q1 2021 and held it in 18 quarters.
  • Freedom Investment Management's CRISPR Therapeutics position peaked at $3.46M in Q2 2021.
  • 440 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q3 2025.

Based on Freedom Investment Management's 13F filing for Q3 2025, filed 14 Nov 2025.